by Indiana University School of Medicine Credit: Pixabay/CC0 Public Domain A study led by Indiana University School of Medicine is challenging standard treatment methods used to prevent muscle damage during heart attack. In a paper published in the Journal of the American College of Cardiology, Rohan Dharmakumar, Ph.D. asserts that a common treatment given to patients experiencing heart attack may...
Year: <span>2022</span>
Adult epilepsy treatment reduces seizures in children
RUTGERS UNIVERSITY A surgical treatment commonly used to reduce epileptic seizures in adults also is effective and safe for children, according to a Rutgers study. The study, published in the journal Neurosurgery, is one of the first to investigate responsive neurostimulation system (RNS)—a device similar to a pacemaker that sends electric charges to the heart, which delivers...
“Deepfaking the Mind” Could Improve Brain-Computer Interfaces for People with Disabilities
Synthetic neurological data created using generative adversarial networks could speed up training of brain-computer interfaces, new study finds. Researchers at the USC Viterbi School of Engineering are using generative adversarial networks (GANs) — technology best known for creating deepfake videos and photorealistic human faces — to improve brain-computer interfaces for people with disabilities. In a paper...
Experimental Gene Therapy Reverses Sickle Cell Disease for Years
A study of an investigational gene therapy for sickle cell disease has found that a single dose restored blood cells to their normal shape and eliminated the most serious complication of the disease for at least three years in some patients. Four patients at Columbia University Irving Medical Center/NewYork-Presbyterian participated in the multicenter study, the first to...
CONVALESCENT PLASMA MAY KEEP COVID-19 PATIENTS OUT OF HOSPITAL
Researchers found that convalescent plasma reduced the need for hospitalization by half for outpatients who participated in the study. Convalescent plasma is plasma from people who have recovered from COVID-19 and whose blood contains antibodies against SARS-CoV-2, the virus that causes COVID-19. CONVALESCENT PLASMA IS THE ONLY ANTIBODY THERAPY THAT “KEEPS UP WITH SARS-COV-2 VARIANTS,”...
Four plant-based foods to eat every week, and why science suggests they’re good for you
by Clare Collins, The Conversation Credit: Shutterstock As a laureate professor in nutrition and dietetics people often ask—what do you eat? Plant-based foods are good sources of healthy nutrients. These include different types of dietary fiber, vitamins, minerals, and a range of “phytonutrients,” which plants produce to help them grow or protect them from pathogens...
Can the COVID-19 delta variant evade vaccine-induced immunity?
Interview conducted by Emily Henderson, B.Sc. Jan 5 2022 Thought LeadersProfessor Brian J. WillettViral Immunologist University of Glasgow In this interview, we speak to Professor Brian J. Willett from the University of Glasgow about his latest research into COVID-19 and whether the delta variant can evade vaccine-induced immunity. Please could you introduce yourself and tell...
The six-minute training hack that can improve face recognition skills
Our brains are wired to recognise faces holistically, but focusing on two standout features can improve performance, a new UNSW study shows. Is that really you on your driver’s licence or passport photo? That is the question facing border security officials, police, security staff, and forensic scientists on a daily basis, especially when automated face...
Boosting the body’s response to infections with a bio-inspired peptide
Peptide molecule developed by USC researchers could help meet the critical need for new drugs to combat antibiotic-resistant bacteria. Somewhere along the long and winding road of evolution, our ancestors lost the ability to produce a small but mighty group of molecules called theta-defensins that help fight bacterial infections. More than seven million years later, researchers...
Researchers urge: ‘Prescribe aspirin based on benefit-to-risk not age’
FLORIDA ATLANTIC UNIVERSITY IMAGE: TO DO THE MOST GOOD FOR THE MOST PATIENTS IN PRIMARY PREVENTION OF HEART ATTACKS AND STROKES, HEALTH CARE PROVIDERS SHOULD MAKE INDIVIDUAL CLINICAL JUDGEMENTS ABOUT PRESCRIBING ASPIRIN ON A CASE-BY-CASE BASIS AND BASED ON BENEFIT-TO-RISK NOT AGE. CREDIT: FLORIDA ATLANTIC UNIVERSITY/GETTY IMAGES Recent guidelines have restricted aspirin use in the...